Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 14 | 2025 | 2680 | 2.260 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 2024 | 43 | 1.630 |
Why?
|
| Pulmonary Fibrosis | 3 | 2024 | 149 | 1.160 |
Why?
|
| Lung | 8 | 2024 | 1337 | 1.140 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2024 | 281 | 1.070 |
Why?
|
| Radiology Information Systems | 2 | 2023 | 78 | 0.880 |
Why?
|
| Lung Neoplasms | 4 | 2024 | 2394 | 0.830 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 469 | 0.820 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2022 | 48 | 0.780 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 120 | 0.720 |
Why?
|
| Myocarditis | 1 | 2021 | 55 | 0.720 |
Why?
|
| Pneumonia | 1 | 2022 | 189 | 0.700 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1186 | 0.600 |
Why?
|
| Spinal Diseases | 1 | 2019 | 77 | 0.600 |
Why?
|
| Lung Diseases | 3 | 2025 | 282 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 694 | 0.520 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 288 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 3509 | 0.490 |
Why?
|
| Transplant Recipients | 1 | 2016 | 152 | 0.460 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 346 | 0.420 |
Why?
|
| Humans | 28 | 2025 | 92337 | 0.370 |
Why?
|
| HIV Infections | 1 | 2020 | 895 | 0.360 |
Why?
|
| Retrospective Studies | 9 | 2024 | 9703 | 0.300 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 156 | 0.280 |
Why?
|
| Aged | 8 | 2024 | 19943 | 0.240 |
Why?
|
| Occupational Exposure | 2 | 2023 | 88 | 0.230 |
Why?
|
| Dyspnea | 1 | 2025 | 80 | 0.230 |
Why?
|
| Middle Aged | 10 | 2024 | 27030 | 0.230 |
Why?
|
| Male | 12 | 2024 | 43925 | 0.220 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2024 | 16 | 0.220 |
Why?
|
| Sensitivity and Specificity | 3 | 2024 | 2009 | 0.220 |
Why?
|
| Societies, Medical | 2 | 2025 | 601 | 0.220 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 10 | 0.210 |
Why?
|
| Pneumoconiosis | 1 | 2023 | 5 | 0.210 |
Why?
|
| Female | 13 | 2024 | 47893 | 0.210 |
Why?
|
| Pleural Effusion | 1 | 2023 | 47 | 0.210 |
Why?
|
| Radiography, Thoracic | 1 | 2025 | 332 | 0.200 |
Why?
|
| Occupational Diseases | 1 | 2023 | 55 | 0.200 |
Why?
|
| Nomograms | 1 | 2022 | 33 | 0.200 |
Why?
|
| Smoking | 2 | 2024 | 640 | 0.200 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 139 | 0.200 |
Why?
|
| Calcinosis | 1 | 2023 | 230 | 0.190 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 145 | 0.190 |
Why?
|
| United States | 3 | 2025 | 7348 | 0.190 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 58 | 0.190 |
Why?
|
| Gadolinium | 1 | 2021 | 104 | 0.180 |
Why?
|
| Radiology | 1 | 2024 | 205 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 206 | 0.180 |
Why?
|
| Inositol | 1 | 2020 | 16 | 0.180 |
Why?
|
| Choline | 1 | 2020 | 25 | 0.180 |
Why?
|
| Medical History Taking | 1 | 2021 | 85 | 0.170 |
Why?
|
| Smoking Cessation | 1 | 2024 | 265 | 0.170 |
Why?
|
| Aspartic Acid | 1 | 2020 | 64 | 0.170 |
Why?
|
| Creatine | 1 | 2020 | 26 | 0.170 |
Why?
|
| Education, Distance | 1 | 2020 | 24 | 0.170 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 131 | 0.170 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 64 | 0.170 |
Why?
|
| Young Adult | 3 | 2021 | 6624 | 0.160 |
Why?
|
| Vaccination | 1 | 2021 | 285 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 316 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2019 | 41 | 0.160 |
Why?
|
| Consensus | 1 | 2021 | 376 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 157 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 167 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 456 | 0.150 |
Why?
|
| Coronary Angiography | 1 | 2019 | 248 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2021 | 340 | 0.150 |
Why?
|
| Vasopressins | 1 | 2018 | 50 | 0.140 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 211 | 0.140 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 101 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 57 | 0.140 |
Why?
|
| Adult | 7 | 2024 | 27532 | 0.140 |
Why?
|
| Brain Edema | 1 | 2018 | 61 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1079 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 269 | 0.140 |
Why?
|
| Pelvis | 1 | 2017 | 96 | 0.130 |
Why?
|
| Contrast Media | 1 | 2021 | 1076 | 0.130 |
Why?
|
| Patient Positioning | 1 | 2017 | 65 | 0.130 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 188 | 0.130 |
Why?
|
| Extremities | 1 | 2017 | 177 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 230 | 0.130 |
Why?
|
| Sarcoma | 1 | 2017 | 216 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2021 | 2037 | 0.120 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 105 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 328 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 313 | 0.120 |
Why?
|
| Risk Factors | 4 | 2021 | 5704 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1763 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 812 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2018 | 405 | 0.110 |
Why?
|
| Global Health | 1 | 2015 | 199 | 0.110 |
Why?
|
| Adolescent | 3 | 2021 | 9504 | 0.110 |
Why?
|
| Incidence | 1 | 2015 | 1661 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1081 | 0.090 |
Why?
|
| Heart Failure | 1 | 2020 | 1346 | 0.080 |
Why?
|
| Brain | 1 | 2020 | 2352 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1038 | 0.080 |
Why?
|
| Pregnancy | 1 | 2016 | 3110 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6916 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2024 | 36 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2025 | 963 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2024 | 353 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1592 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 559 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 1503 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 675 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 252 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2018 | 46 | 0.040 |
Why?
|
| Catecholamines | 1 | 2018 | 92 | 0.040 |
Why?
|
| Rotation | 1 | 2017 | 93 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 2978 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1927 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 390 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 498 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 612 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 471 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1902 | 0.030 |
Why?
|
| Child | 1 | 2017 | 7334 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8740 | 0.010 |
Why?
|